BrachyBytes

In This Issue

Device Placement

2010 MDEA Awards

SAVI Delivers Lowest Dose

BrachyBytes Editorial Advisory Board

 

Robert Kuske, M.D.
Coral Quiet, M.D
Jay Reiff, Ph.D.
Dan Scanderbeg, Ph.D.
John Sweet, M.S.

Catheryn Yashar, M.D.


Vic Zannis, M.D.


Upcoming Events

American Society of Breast Surgeons
April 28-May 2, 2010
Las Vegas

American Brachytherapy Society
April 29-May 1, 2010
Atlanta

 

Follow-up Links

Past Issues
MD Anderson Cancer Center
2010 MDEA Awards
MD&DI
ASBS
ABS

April 2010

Device Placement:
Prep Catheter vs Percutaneous Implant?

The SAVI ApplicatorHow do you prefer to do your SAVI placements – a percutaneous implant under ultrasound guidance, or using the SAVI Prep Catheter in the OR?

Surgeon Gildy Babiera, M.D., F.A.C.S. of MD Anderson Cancer Center discusses the advantages and disadvantages of each method, as well as why collaboration between surgeons and radiation oncologists is the key to quality patient care.
Read More

VIDEO: Watch Dr. Michael Berry of the Breast Clinic of Memphis do a percutaneous implant

 

SAVI Named 2010 MDEA Winner

Earlier this month, the SAVI applicator was named a winner in the 2010 Medical Design Excellence Award (MDEA) competition,

the
only awards program that exclusively recognizes contributions and advances in
the design of medical products.

Read about all 2010 MDEA winners in the April issue of MD&DI

The MDEA competition recognizes the achievements of medical device manufacturers, their suppliers and the many people behind the scenes – engineers, scientists, and clinicians – who are responsible for creating innovative products that are changing the face of healthcare.

While Cianna Medical is proud to receive this honor, we realize our design accomplishments would be meaningless without our customers’ commitment to APBI and the SAVI applicator.

We want to thank all of the physicians who are changing how we care for women with early-stage breast cancer by recognizing the benefit of more targeted radiation therapy and choosing to make it available to their patients.

 

Study: SAVI Delivers Lowest Dose

A study published in the Winter 2010 issue of Journal of Applied Clinical Medical Physics concluded that SAVI is better able to adapt to patient anatomy than MammoSite and 3D-CRT.

The paper, authored by Dan Scanderbeg, Ph.D. et al., from UC San Diego, found that dose to normal tissue was lowest with SAVI, with 51.5%, 64.7% and 75.0% delivered to the skin, lung and chest/wall respectively.

Read “Evaluation of three APBI techniques under NSABP-39